Abstract. Medulloblastoma is the most frequent type of childhood brain tumour. The insulin-like growth factor I receptor (IGF-IR) plays a significant neuroprotective role in medulloblastoma survival through regulation of the downstream effectors of the phosphoinositide-3-kinaseprotein kinase-B (PI3K-PKB/c-Akt) pathway. One such target is Forkhead box O1 (FOXO1; FKHR), which is part of the FOXO family of Forkhead transcription factors. Phosphorylation by Akt results in cytoplasmic sequestration of FOXO1 thus inhibiting the expression of genes controlling cell death, cell proliferation, differentiation, cellular metabolism and oxidative stress. Here we show that serum starvation of medulloblastoma cells is accompanied by nuclear translocation of FOXO1. IGF-I stimulation of serum-starved cells resulted in rapid phosphorylation of Akt and FOXO1, and was associated with a significant increase in cell viability. In contrast, expression of a constitutively active form of FOXO1 that cannot be phosphorylated led to a significant reduction in medulloblastoma cell viability, even in the presence of growth factors provided by fetal bovine serum (FBS). These data suggest that the transcription factor FOXO1 may be a critical effector of medulloblastoma growth suppression.
Introduction
Medulloblastoma is a highly malignant tumour of the cerebellum that represents about 20-25% of all paediatric intracranial neoplasms with the peak incidence occurring between 5 and 9 years of age (1, 2) . Despite aggressive therapy, which includes surgical debulking, craniospinal irradiation and chemotherapy, the 5-year survival rate hovers around 50-70% with children under 3 years of age faring much worse (3, 4) . Furthermore, there are considerable neuropsychological sequelae amongst survivors secondary to both the disease and the treatment (5) .
The exact origin of medulloblastoma remains unknown although evidence suggests derivation from the granule cell precursors found in the external germinal layer of the developing cerebellum (6, 7) . A few potential underlying mechanisms of medulloblastoma initiation and progression have been revealed, which include chromosomal alterations and dysregulation of cell signaling systems (8, 9) . The PI3K/Akt pathway has been implicated in medulloblastoma cell survival and medulloblastoma tumour formation in humans and in an animal model of the tumour (10, 11) . The majority of tumour specimens examined to date have shown immunohistochemical staining for activated Akt (phosphorylation of Ser473) (12, 13) . Furthermore, overexpression of constitutively active Akt in medulloblastoma cell lines reverses the proliferative arrest elicited by the PI3K inhibitor, LY294002 (12) . As well, in the ptc +/-mice, which spontaneously develop medulloblastoma at a somewhat low frequency (15-20%) , activation of the Akt pathway increases tumour incidence (10, 14) .
Upon phosphorylation by PI3K, activated Akt can phosphorylate a variety of substrates, including the proapoptotic Bcl-2 family member Bad; caspase-9; nuclear factor-κB; mammalian target of rapamycin; mdm2; and the Forkhead family of transcription factors, FOXO1 (FKHR), FOXO3a (FKHRL1) and FOXO4 (AFX) suggesting a multifactorial mechanism in mediating cell survival through blockade of apoptosis (15, 16) . In established cell lines, the Forkhead family of transcription factors augments the expression of the cyclin-dependent kinase inhibitor p27 kip1 causing cell cycle arrest; further FOXO-induced transcriptional upregulation of FasL and Bim genes can trigger apoptosis (17) . Phosphorylation by Akt leads to nuclear export and cytoplasmic retention of FOXO members, preventing activation of gene targets related to growth arrest and apoptosis thereby allowing the target cells to proliferate and/or survive (15, 16) .
There is currently a dearth of information on the effects of the Forkhead family of transcription factors on the survival of medulloblastoma cells. Consequently, the major aim of this study was to assess the effects of the FOXO transcription factors on medulloblastoma cell survival. We have found that upon serum starvation of the DAOY and UW228-3 human medulloblastoma cell lines, FOXO1 (FKHR) translocates to the nucleus. Furthermore, a constitutively active form of FOXO1 (FOXO1-AAA) that cannot be phos-phorylated by Akt was sufficient in significantly reducing medulloblastoma cell viability.
Materials and methods
Cell lines. The DAOY (American Type Culture Collection; Rockville, MD) and UW228-3 (18) (a gift of Dr Rolando Del Maestro; McGill University, Montreal, Canada) medulloblastoma human cell lines were cultured in 10-cm plates containing Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, Grand Island, NY) supplemented with 10% fetal bovine serum at 37˚C in a 5% CO 2 atmosphere.
Treatments. Cells were first grown in 10-cm plates until 70-80% confluency followed by cellular detachment with 5 mM EDTA and plating into 6-well plates at a density of 5x10 4 cells per well in complete serum (DMEM supplemented with 10% FBS). In order to make cells quiescent, after 24 h, the culture medium was replaced with serum-free medium solution (DMEM supplemented with 0.1% bovine serum albumin) for 48 h. Cell viability response to IGF-I (Intergen Co., Purchase, NY) by stimulation of quiescent serum starved DAOY cells with 10 and 100 ng/ml IGF-I, was assessed by a colorimetric assay with the dye (2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide) sodium salt (XTT; Sigma, St. Louis, MO). To investigate the short-term kinetics of phosphorylation of Akt (Cell Signaling Technology, Beverly, MA) and p44/42 MAPK (Cell Signaling Tech.), cells were exposed to IGF-I for 2, 10, 60 and 120 min; cell lysates were subsequently collected for Western blot analysis. To study the effect of IGF-I on the phosphorylation of Akt, p44/42 MAPK and FOXO1 (Cell Signaling Tech.), cells were treated with either LY294002 (25 μM; Calbiochem, San Diego, CA) or PD98059 (50 μM; Calbiochem) for 2 min, 10 min, 1 h and 24 h following stimulation with IGF-I (100 ng/ml) for 24 h. Subsequently, lysates were collected for Western blot analysis.
Western blotting. Briefly, cells from different experimental treatment conditions were rinsed in ice-cold PBS and lysed in sample buffer [30 mM Tris (pH 8.0), 150 mM NaCl, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 1% Triton X-100, 0.5% sodium deoxycholate, complete EDTA-free protease inhibitor tablet(s)]. Samples with equal amounts of protein were then resolved by denaturing 10% polyacrylamide gel electrophoresis and electrotransferred to Hybond-ECL nitrocellulose membranes. Membranes were then incubated in 0.1% Ponceau red to determine protein loadings followed by incubation in 5% non-fat milk in TBST [20 mM Tris-HCl (pH 8.0), 150 mM NaCl and 0.2% Tween-20] for 1 h at room temperature and then incubation with the appropriate primary antibody [anti-phospho-Akt (Ser 473), 1:1000; anti-phospho-FOXO1 (Ser 256), 1:1000; anti-Akt, 1:1000; anti-FOXO1, 1:1000; anti-caspase-9, 1:500, Cell Signaling Tech.]; anti-p27, 1:1000 (Santa Cruz Biotechnology, Santa Cruz, CA); anticyclin D1, 1:1000 (NeoMarker, Fremont, CA) and anti-ß-actin, 1:1000 (abcam, Cambridge, UK) at 4˚C overnight. The membranes were then rinsed thrice in TBST and probed with the corresponding secondary antibodies [anti-rabbit (1:1000; Cell Signaling Tech.)/anti-mouse (1:1000; Dako, Glostrup, Denmark)] conjugated with horseradish peroxidase at room temperature for 1 h. Membranes were finally washed thrice in TBST to remove unbound secondary antibodies prior to revelation using the BLAZE kit (Pierce Biotechnology Inc., Rockford, IL).
Immunofluorescence studies. DAOY cells were plated into wells within the Lab-Tek chamber slide system (Nalge Nunc International, Naperville, IL) at a density of 10 4 cells per well in complete serum. After 24 h, serum starvation was carried out in which the medium was replaced with DMEM (containing 0.1% BSA) for varying times (1, 3, 12 and 24 h). After each time point cells were rinsed twice in ice-cold PBS and fixed with 4% paraformaldehyde in PBS for 10 min and permeabilized with ice-cold acetone: methanol (1:1) for 10 min. After blocking with 5% BSA in PBS containing 0.1% Triton-X-100 for 1 h at room temperature, primary antibody incubation was performed for 16 h at 4˚C using anti-FOXO1 (1:100) diluted in 5% BSA in PBS. After two washes in PBS, incubation in the appropriate secondary antibody (Alexa Fluor 555; Molecular Probes, OR) diluted in 5% BSA (1:1000) was done for 1 h at room temperature. During the last 10 min of the incubation, Hoechst 33258 (1:1000) was added. Slides were visualized on a Leica DMIRE2 (Richmond Hill, Ontario, Canada) wide-field fluorescence microscope equipped with a CCD camera. The same exposure time was used for all samples. The images were processed using Openlab (Lexington, MA) software. A similar procedure was also utilized for observing FOXO1 translocation during serum-starvation of UW228-3 medulloblastoma cells.
Adenovirus preparation and infection. Ad-FOXO1-AAA (Ad-FKHR-AAA) was a kind gift of Dr W.R. Sellers (Cambridge, MA). It was generated with the pAD-Easy system described previously (19) . Ad-FOXO1-AAA, and Ad-LacZ were amplified in 293A cells and purified by freeze-thaw extraction followed by CsCl gradient purification. Viruses were titered by monitoring cytopathic effect on 293A cells. DAOY cells were grown in 10-cm dishes until 80-90% confluency. These cells were then serum starved for 2 days prior to plating the cells in 6-well plates containing serum-free medium. Selected wells were supplemented with IGF-I (100 ng/ml) and allowed to grow for 24 h at 37˚C/5% CO 2 . Subsequently, Ad-FOXO1-AAA was added at MOI 100 and the control Ad-LacZ was added at the same MOI to ascertain the possibility of non-specific viral toxicity. DAOY cells were exposed to the viral treatment for 24, 48 and 72 h at 37˚C/ 5% CO 2 . For each time-point, cell viability was assessed with the XTT assay (Sigma). For adenoviral transduction into 10% FBS containing media, DAOY or UW228-3 cells were first counted and allowed to adhere for about 6 h prior to transduction with Ad-FOXO1-AAA, Ad-LacZ or Ad-BFP at their respective MOIs. Both medulloblastoma cell lines were exposed to viral treatment for 24, 48 and 72 h at 37˚C/ 5% CO 2 prior to XTT viability assessment.
Results

FOXO1 undergoes nuclear translocation during serum starvation.
Medulloblastoma cell lines in culture are sensitive to serum deprivation. In both the DAOY and UW228-3 cell lines, upon withdrawal of serum, metabolic activity diminishes and cell numbers decrease (Fig. 1) .
As the PI3K/Akt pathway has been implicated in medulloblastoma survival, we examined a distal target of the PI3K/Akt pathway, FOXO1 during serum starvation of DAOY and UW228-3 cell lines. FOXO1 was chosen as a representative of the FOXO family of Forkhead transcription factors, which include FOXO1, FOXO3a and FOXO4. To examine the localization of FOXO1 transcription factor upon growth factor withdrawal, DAOY cells were placed into serum-free media for varying periods of time. Endogenous FOXO1 was primarily confined to the cytoplasm of DAOY cells proliferating in 10% fetal bovine serum (Fig. 2) . Transfer of these cells to serum-free medium [containing 0.1% bovine serum albumin (BSA)] resulted in FOXO1 re-localization to the nucleus after 24 h with progressively stronger FOXO1-positive immunoreactivity being observed within Hoechstpositive nuclei (Fig. 2A) . Analysis of 6 high-power fields (hpf) per time point revealed that most of the FOXO1-positive nuclei are observed after 24 h (Fig. 2A) . Nuclear FOXO1 immunoreactivity was also observed in serum-starved UW228-3 medulloblastoma cells, which displayed reduced viability ( Figs. 1 and 2C ). These results show that serum starvation of the medulloblastoma cells is accompanied by nuclear translocation of FOXO1. Subsequently, cells were stained with anti-FOXO1 (Alexa Fluor 555; red) and Hoechst 333248 (nuclear stain; blue) and images were captured with a fluorescent microscope as described in Materials and methods. (B) Graphical representation of FOXO1 nuclear localization in DAOY medulloblastoma cells; bars represent mean ± SEM from at least six independent high-power field. P-value was determined by using One-way ANOVA with Bonferroni's multiple comparison post-test. (C) Endogenous FOXO1 nuclear localization in UW228-3 cells after 24 h serum starvation as visualized by 63x oil immersion. the PI3K/Akt pathway (20, 21) . The human medulloblastoma cell line, DAOY, expresses IGF-IR suggesting the potential for these cells to respond to IGF-I (Fig. 3A) . The DAOY cells express almost equivalent levels to that of the rat glioma cell line, C6LacZ, which was used as a positive control for IGF-IR (22); IGF-IR expression was also observed in the UW228-3 human medulloblastoma cell line (data not shown). The IGF-IR in these cells is functional as IGF-I can significantly increase the viability of serum-starved DAOY in response to IGF-I stimulation (Fig. 3B) . When the DAOY cell line was cultured in serum-free medium for 48 h prior to stimulation with IGF-I (10 and 100 ng/ml) for 24, 48 and 72 h, IGF-I rescued DAOY cells in a dose-dependent manner. These results indicate that IGF-I can lead to survival of medulloblastoma cells under low-serum conditions.
Expression of IGF-IR and IGF-I-dependent
Treatment with IGF-I was associated with a rapid phosphorylation of Akt within 2 min of stimulation with IGF-I (100 ng/ml) and which was sustained for at least 24 h post-IGF-I stimulation (Fig. 3C) . Of interest, IGF-I induces rapid FOXO1 phosphorylation (Fig. 3D) , which is sensitive to treatment with the PI3K/Akt inhibitor LY294002, but insensitive to the Ras-MAPK inhibitor, PD98059, as unphosphorylated FOXO1 appears within 10 min of LY294002 inhibitor administration while it remains phosphorylated in the presence of PD98059 (Fig. 3D) . Thus, IGF-I rescues DAOY cells from serum starvation, possibly through the downstream phosphorylation of FOXO1.
Activated FOXO1-AAA significantly suppresses medulloblastoma viability.
A mutant form of FOXO1 (FOXO1-AAA), containing three modified Akt phosphorylation sites (Ser, Thr to Ala), cannot be negatively regulated by Akt. Thus, adenoviral expression of FOXO1-AAA was utilized to restore FOXO1 activity to DAOY cells in an attempt to ascertain the effects of constitutively active FOXO1 on medulloblastoma viability. DAOY cells were first serum starved for 48 h prior to treatment with IGF-I for 24 h. These cells were then exposed to either Ad-FOXO1-AAA (Ad-A3) or Ad-LacZ at MOIs (multiplicity of infection) of 100 and assessed for viability after 24, 48 and 72 h [all DAOY cells are transduced at this MOI (Fig. 4A) ]. Cells infected with Ad-LacZ showed similar viability to that of mock-infected cells (Fig. 4B) . However, the viability of Ad-FOXO1-AAA infected DAOY was significantly reduced compared to that of both Ad-LacZ treated and mock-infected cells (Fig. 4B) . Interestingly, Ad-FOXO1-AAA infected DAOY which were exposed to complete serum displayed a similar trend. Cells that were infected with Ad-LacZ at MOIs of 100 and 500 showed similar viability to mock-infected cells (Fig. 5A) . In contrast, the viability of Ad-FOXO1-AAA infected DAOY grown in complete serum was significantly reduced at both MOIs as compared to cells that were infected with Ad-LacZ (Fig. 5A) . Furthermore, Ad-FOXO1-AAA infections carried out at MOI 500 were able to reduce DAOY viability constantly over a 3-day period. Similarly, viability of UW228-3 medulloblastoma cells growing in complete serum significantly decreased after Ad-FOXO1-AAA transduction at MOIs of 50 and 100 (Fig. 5B) . In cells transduced with Ad-FOXO1-AAA, Western blot analysis of selected FOXO1 targets showed an increase in the cyclin-dependent kinase inhibitor p27 and a concomitant decrease in cyclin D1 (and cyclin D2, data not shown) as compared to cells transduced with AdLacZ or mock treated (Fig. 6) . Importantly, only Ad-FOXO1-AAA-transduced cells had activated caspase 9 (Fig. 6 ). Thus, a FOXO1 construct that cannot be negatively regulated by Akt is a critical direct regulator of medulloblastoma cell survival in the absence or presence of growth factors.
Discussion
Data from studies in nematode and mammalian cells suggest that regulation of the Forkhead family of transcription factors is key to many cellular responses which include apoptosis, cell cycle function, stress and metabolic responses (17, 23) . The major targets of the serine-threonine kinase Akt are the Forkhead factors; however there is a dearth of data regarding the involvement of the IGF-I-FOXO1 axis in the survival of medulloblastoma. Here we report that retention of FOXO1 in the cytoplasm is key to medulloblastoma survival and that enforced expression of a constitutively active FOXO1 can dramatically reduce medulloblastoma cell viability. It has been shown that IGF-I can stimulate FOXO3a/FKHRL1 phosphorylation in neuronal cells via the PI3K-Akt pathway thus inhibiting this pro-apoptotic transcription factor (24) . The common mechanism for inhibition has been attributed to phosphorylation of the FOXO factors via insulin or other growth factor signaling cascades leading to their retention in the cytoplasm and thus repression of pro-apoptotic genetic programs (17) . For example, in cerebellar granule cells, the ultimate phenotypic response for FOXO regulation by the IGF-I signaling cascade is the blockade of FOXO3a/FKHRL1-dependent transcription of Bim, which is a principal player in initiating the intrinsic (mitochondrial) apoptotic pathway (25) . Furthermore, nuclear exclusion of FOXO1 induced via phosphorylation by insulin serves to target FOXO1 for ubiquitin-mediated degradation (26) . We have shown for the first time in medulloblastoma cells that FOXO1 is phosphorylated upon sole IGF-I stimulation subsequent to serum starvation (Fig. 3D) . Furthermore, IGF-I-induced FOXO1 phosphorylation appears to be PI3K-dependent rather than dependent on the MAPK pathway. Thus, in the medullo- blastoma cells, integrity of the PI3K-Akt pathway is required for FOXO1 phosphorylation, in accordance with previous findings in other cell types (17, 23, 24, 26, 27) .
Upon serum starvation of the medulloblastoma cells, the subcellular localization of FOXO1 was primarily nuclear. This observation is in agreement with the commonly held hypothesis that in the absence of IGF-I signaling FOXO1 is no longer phosphorylated and thus can be imported into the nucleus to effect target gene expression. Serum starvation led to a drastic reduction in medulloblastoma cell viability (Fig. 1) . The findings of nuclear FOXO1 localization and low medulloblastoma viability upon serum starvation prompted us to investigate the link between the regulation of FOXO1 status and medulloblastoma survival. Since phosphorylated FOXO1 has been hypothesized to lead to cell survival, a dominant-negative form of FOXO1 (FOXO1-AAA), in which the three Akt phosphorylation sites are altered, was used to test the null hypothesis that medulloblastoma cell death requires FOXO1 to be constitutively non-phosphorylated in the presence of growth factor signaling. We report here that adenovirus-mediated delivery of FOXO1-AAA into medulloblastoma cells can reduce cell viability (Figs. 4-6 ), which is in keeping with other published reports demonstrating a regulatory role for FOXO1 in apoptosis (28) (29) (30) (31) . Indeed, a recent study demonstrated that pharmacological inhibition of the p85 subunit of PI3K in human breast carcinoma cells leads to activation of FOXO transcription factors and subsequent transcriptional induction of cell cycle arrest and apoptotic genes (32) . As well, dramatic apoptosis of LAPC4 prostate carcinoma cells occurred upon adenovirus-mediated overexpression of FOXO1 and FOXO3a (33) . Interestingly, in our study, Ad-FOXO1-AAA treatment significantly abrogated medulloblastoma viability in the presence of complete serum (Figs. 5 and 6 ), which suggests that FOXO1 may represent an important convergence point for multiple signaling pathways.
Taken together, the data presented here support a novel role for FOXO1 in medulloblastoma viability and furthermore, demonstrate that adenoviral expression of a mutant form of FOXO1 (FOXO1-AAA), which cannot be phosphorylated, can induce efficient growth suppression of medulloblastoma cell lines. Thus, means of inhibiting FOXO1 nuclear export (34) might provide important therapeutic applications, allowing the activity of a single downstream transcription factor, such as FOXO1, to overcome defects in tyrosine kinase receptor signalling through the PI3K-Akt pathway.
